As of July 17, 2025, the FDA granted marketing authorization for the Juul device and JUULpods in Virginia tobacco and menthol flavors. This is a significant distinction, though: the FDA does not “approve” tobacco products the way it approves drugs or medical devices. Instead, it “authorizes” them for sale after determining that marketing the product is appropriate for public health. Juul is now one of a small number of e-cigarettes legally permitted for sale in the United States.
Authorization vs. Approval: Why the Wording Matters
When the FDA approves a drug or medical device, it’s confirming that the product is safe and effective for its intended use. Tobacco products go through a completely different process. Because no commercial tobacco product can be considered “safe and effective,” the law instead requires manufacturers to demonstrate that allowing their product on the market won’t cause additional harm to public health overall. That’s a much lower bar than a stamp of safety.
So when you see that Juul has been “FDA authorized,” it means the agency reviewed the evidence and concluded that keeping Juul on the market is unlikely to make the public health picture worse, not that Juul is safe to use. The product is not a cessation device, and the authorization doesn’t encourage anyone to start vaping.
What the FDA Actually Reviewed
The FDA evaluates e-cigarettes through the Premarket Tobacco Product Application (PMTA) process. Two big questions drive the review. First, does the product make it more likely that current smokers will switch away from cigarettes? Second, does the product make it more likely that people who don’t use tobacco, especially young people, will start?
For Juul, the FDA’s toxicology review found that the aerosol from JUULpods contains fewer harmful chemicals and at lower levels than conventional cigarette smoke. The agency’s analysis estimated that the excess lifetime cancer risk from using Juul products is significantly lower than from smoking, coming in at less than 5% of the cancer risk associated with a standard reference cigarette. Biomarker studies showed that levels of multiple cancer-linked compounds in the body drop substantially when cigarette smokers switch to Juul.
The review wasn’t without concerns. The FDA flagged two chemical leachables in the pods whose exposure levels exceeded toxicological safety thresholds, suggesting possible non-cancer health risks. For menthol pods specifically, the inclusion of certain additional chemical constituents shifted the overall cancer risk comparison from “lower concern” to “moderate concern” relative to cigarettes. These findings didn’t block authorization, but they formed part of the risk-benefit calculation.
Juul’s Complicated Regulatory History
Juul’s path to authorization was anything but smooth. In June 2022, the FDA initially issued a Marketing Denial Order, effectively banning Juul products from the U.S. market. Within weeks, however, the agency reversed course and placed that order on administrative hold, citing “scientific issues unique to the JUUL application that warrant additional review.” During the hold, Juul products remained on shelves, but the FDA made clear that the stay did not constitute authorization to sell.
That limbo lasted roughly three years. During that period, Juul continued selling its products while the agency completed its review. The final marketing granted order came in July 2025, resolving years of legal and regulatory uncertainty.
Which Juul Products Are Authorized
The authorization covers a limited set of products:
- The Juul device (the battery unit itself)
- Virginia Tobacco JUULpods in 3.0% and 5.0% nicotine strengths
- Menthol JUULpods in 3.0% and 5.0% nicotine strengths
Fruit, dessert, and other flavored pods that Juul once sold are not authorized. The company pulled those flavors from the market years ago amid intense scrutiny over youth vaping, and they have no legal path back to store shelves under the current order.
How Juul Compares to Other Authorized E-Cigarettes
Only 41 e-cigarette products total have received FDA marketing authorization. The authorized landscape is dominated by a handful of companies. Vuse, made by R.J. Reynolds, holds the largest share of authorizations with 16 products including several Alto pod options in tobacco flavors. NJOY has 10 authorized products spanning its Daily and Ace lines. Logic holds authorization for several cartridge and liquid configurations. Juul’s five authorized products (the device plus four pod varieties) and Glas round out the list.
The vast majority of e-cigarettes sold in the U.S., particularly disposable brands popular with younger users, have never received FDA authorization. Among youth who currently vape, the most commonly reported brands in 2024 were Elf Bar (36.1%), Breeze (19.9%), Mr. Fog (15.8%), Vuse (13.7%), and Juul (12.6%). Overall youth e-cigarette use dropped to 1.63 million middle and high school students in 2024, down from 2.13 million the year before, with most of that decline coming from high schoolers.
What Authorization Means for You
If you’re a current smoker considering switching to Juul, the FDA’s authorization means the agency has reviewed the available science and determined that Juul’s toxicant profile is substantially lower than cigarettes. That’s meaningful, but it’s not a green light for health. Nicotine itself is highly addictive, and the long-term effects of inhaling e-cigarette aerosol over decades remain unknown.
If you don’t currently use nicotine or tobacco products, nothing about this authorization changes the basic calculus: starting to vape introduces nicotine dependence and chemical exposure you wouldn’t otherwise have. The FDA weighed exactly this tradeoff, the benefit to smokers who switch versus the risk of new users picking up the habit, when making its decision.